We are live on ! Find out more
JIP

Jaffetilchin Investment Partners Portfolio holdings

AUM $1.68B
1-Year Est. Return 22.81%
This Fund
S&P 500
This Quarter Est. Return
+3.55%
1 Year Est. Return
+22.81%
3 Year Est. Return
+78.52%
5 Year Est. Return
+93%
10 Year Est. Return
+323.14%
AUM
$296M
AUM Growth
-$97.9M
Cap. Flow
-$107M
Cap. Flow %
-36.06%
Top 10 Hldgs %
40%
Holding
313
New
59
Increased
25
Reduced
134
Closed
93
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLE icon
301
State Street Energy Select Sector SPDR ETF
XLE
$39.8B
-127,198
Closed -$4.45M
XMLV icon
302
Invesco S&P MidCap Low Volatility ETF
XMLV
$740M
-11,573
Closed -$490K
XOM icon
303
ExxonMobil
XOM
$657B
-11,538
Closed -$946K
XSLV icon
304
Invesco S&P SmallCap Low Volatility ETF
XSLV
$247M
-12,203
Closed -$523K
PXD
305
DELISTED
Pioneer Natural Resource Co.
PXD
-3,761
Closed -$700K
PACW
306
DELISTED
PacWest Bancorp
PACW
-5,335
Closed -$284K
DNKN
307
DELISTED
Dunkin' Brands Group, Inc.
DNKN
-10,966
Closed -$600K
MBFI
308
DELISTED
MB Financial Corp
MBFI
-7,437
Closed -$318K
MSCC
309
DELISTED
Microsemi Corp
MSCC
-6,160
Closed -$317K
SNI
310
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
-11,357
Closed -$890K
RAI
311
DELISTED
Reynolds American Inc
RAI
-3,464
Closed -$218K
CELG
312
DELISTED
Celgene Corp
CELG
-3,045
Closed -$379K
STL
313
DELISTED
Sterling Bancorp
STL
-14,051
Closed -$333K

Similar funds

Jaffetilchin Investment Partners's Q2 2017 Portfolio in Review

As of Q2 2017, Jaffetilchin Investment Partners held 313 positions worth $296M, down 25% from $393M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Jaffetilchin Investment Partners withdrew a net $107M in Q2 2017, closing 93 positions and reducing 134 holdings. Its most notable exit was First Trust Preferred Securities and Income ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 5.5% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jaffetilchin Investment Partners opened a new position in Jazz Pharmaceuticals worth $1.49M.

  • Jaffetilchin Investment Partners's largest Q2 2017 buy was Jazz Pharmaceuticals: 9,559 shares worth $1.49M.
  • Jaffetilchin Investment Partners added most to Opko Health in Q2 2017, an estimated $2.48M increase.
  • Jaffetilchin Investment Partners's biggest Q2 2017 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $8.24M.
  • Jaffetilchin Investment Partners fully exited First Trust Preferred Securities and Income ETF in Q2 2017, selling an estimated $13.7M.
  • Jaffetilchin Investment Partners's ten largest holdings make up 40% of its $296M portfolio in Q2 2017.
  • Jaffetilchin Investment Partners opened 59 new positions and closed 93 in Q2 2017.
  • Jaffetilchin Investment Partners's portfolio value fell 25% quarter-over-quarter to $296M.

Based on Jaffetilchin Investment Partners's 13F filing for Q2 2017, filed 3 Aug 2017.